Related Experiment Videos
[Predictive factors of response to electronarcosis]
1Service Hospitalo-Universitaire de Santé Mentale et de Thérapeutique, Hôpital Sainte-Anne, Paris.
L'Encephale
|December 1, 1991
Summary
Electroconvulsive treatment (ECT) is effective for many, but 10-20% of patients with depression remain refractory. Research is ongoing to identify predictors of ECT efficacy for better treatment outcomes.
Area of Science:
- Neuroscience
- Psychiatry
Context:
- Electroconvulsive treatment (ECT) is a recognized therapy for depression when antidepressant medications fail.
- Despite its general efficacy, a significant portion of patients (10-20%) do not respond to ECT, necessitating predictive research.
Purpose:
- To explore factors that predict the efficacy or lack thereof for electroconvulsive treatment in patients with depression.
- To identify reliable pre-treatment and during-treatment indicators of ECT response.
Summary:
- Current clinical and biological predictors for ECT efficacy in depression are limited.
- While some studies suggest the importance of epileptogenic threshold and pituitary peptide levels, further validation is needed.
- Therapeutic practices like seizure duration and total seizure time are valued, aligning with discussions on ECT dosage and electrode placement (unilateral vs. bilateral).
Impact:
- Identifying reliable predictors can personalize ECT protocols, improving outcomes for treatment-refractory depression.
- This research can guide clinical decision-making, optimizing the use of ECT and subsequent treatment strategies.
- Further investigation into biological markers and therapeutic parameters will enhance the understanding and application of ECT.